ACON
Aclarion, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$2.35
+2.62%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 83.8K | 75.7K | 45.7K | 75.4K | 60.4K |
| Cost of Revenue | 126.5K | 296.3K | 129.8K | 75.7K | 65.3K |
| Gross Profit | (42.7K) | (220.6K) | (84.0K) | (324.00) | (4.9K) |
| Operating Expenses | |||||
| R&D Expense | 1.2M | 1033.8B | 888.8K | 873.3K | 1.1M |
| SG&A Expense | 8.6M | 6025.4B | 4.6M | 4.0M | 4.5M |
| General & Admin Expense | 5.5M | 4124.8B | 3.6M | 3.2M | 4.0M |
| Selling & Marketing Expense | 3.0M | 1900.6B | 976.6K | 757.0K | 498.0K |
| Other Expenses | (60.9K) | (7059.2B) | (45.1K) | — | — |
| Total Operating Expenses | 9.7M | 6.8M | 5.4M | 4.9M | 5.6M |
| Cost and Expenses | 9.8M | 7.1M | 5.6M | 5.0M | 5.6M |
| Operating Income (EBIT) | (9.7M) | (7.1M) | (5.5M) | (4.9M) | (5.6M) |
| Non-Operating | |||||
| Interest Income | 290.4K | 411.1K | 318.00 | 172.00 | 2.5K |
| Interest Expense | — | — | 535.5K | 608.3K | 1.5M |
| Net Interest Income | 290.4K | 411.1K | (535.2K) | (608.1K) | (1.5M) |
| Other Non-Op Income/Expense | 514.1K | (181.2K) | (1.5M) | (35.4K) | (1.5M) |
| Non-Operating Income (excl Interest) | (514.1K) | 181.2K | 944.4K | (572.9K) | (521.00) |
| EBT (Pre-Tax Income) | (9.2M) | (7.2M) | (7.0M) | (4.9M) | (7.1M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (9.2M) | (7.2M) | (7.0M) | (4.9M) | (7.1M) |
| Earnings from Cont. Ops | (9.2M) | (7.2M) | (7.0M) | (4.9M) | (7.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (9.2M) | (7.2M) | (7.1M) | (4.9M) | (7.5M) |
| Per Share | |||||
| Basic EPS | ($7.60) | ($13.61) | ($7,480.22) | ($79,782.00) | ($177,396.00) |
| Diluted EPS | ($7.60) | ($13.61) | ($7,480.22) | ($79,782.00) | ($177,396.00) |
| Revenue Per Share | $0.03 | $0.14 | $48.50 | $1,224.89 | $1,432.70 |
| Shares | |||||
| Basic Shares Outstanding | 2.5M | 532036 | 943 | 62 | 42 |
| Diluted Shares Outstanding | 2.5M | 532036 | 943 | 62 | 42 |
| Profitability Metrics | |||||
| EBITDA | (9.0M) | (7.0M) | (6.3M) | (4.1M) | (5.4M) |
| D&A | 242.5K | 227.4K | 193.1K | 162.7K | 143.6K |
| EBIT | (9.2M) | (7.2M) | (6.5M) | (4.3M) | (5.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026